The body’s own cannabinoids widen the bronchial tubes

Inhalation therapy for asthma and other obstructive lung diseases often loses its effect following prolonged use. A research team has now shown an alternative signalling pathway through which the body’s own cannabinoids cause the bronchial tubes to dilate. This gives rise to hope for alternative treatment options. Asthma is evidently also associated with a deficiency of these cannabinoids in the bronchial tubes, which could be one of the causes of the disease.

Leave a Comment